- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Lenalidomide placebo
Total 54807 results
-
Second Affiliated Hospital of Soochow UniversityEnrolling by invitationDiffuse Large B-cell LymphomaChina
-
Celgene CorporationCompletedMultiple MyelomaUnited States
-
Bristol-Myers SquibbRecruitingMultiple MyelomaCanada, Taiwan, United States, Australia, Denmark, China, Korea, Republic of, Israel, Spain, France, Germany, Czechia, Austria, Japan, Sweden, United Kingdom, Greece, Italy, Finland, Argentina, Belgium, Brazil, Colombia, Hong Kong, India, Mexic... and more
-
Huiqiang HuangRecruitingHigh-grade B-cell Lymphoma | Transformed Lymphoma | EBV-Positive DLBCL, Nos | ALK-Positive Anaplastic Large Cell Lymphoma | Non-GCB/ABC Diffuse Large B-Cell Lymphoma | Follicular Lymphoma Grade IIIbChina
-
Hoffmann-La RocheActive, not recruitingFollicular LymphomaUnited Kingdom, United States, China, France, Spain
-
CelgeneCompletedMultiple MyelomaKorea, Republic of, United States, France, Belgium, Canada, Spain, United Kingdom, Australia, Italy, New Zealand, China, Portugal, Switzerland, Taiwan, Austria, Greece, Germany, Ireland, Sweden
-
University Health Network, TorontoCelgene CorporationCompleted
-
Vaishali SanchorawalaCelgene CorporationCompletedMultiple MyelomaUnited States
-
University of Michigan Rogel Cancer CenterCelgene; Onyx Therapeutics, Inc.CompletedMultiple MyelomaUnited States
-
University of PennsylvaniaActive Biotech ABRecruiting
-
Mayo ClinicCompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma | Recurrent Grade... and other conditionsUnited States
-
Chong Kun Dang PharmaceuticalUnknownMyeloma, MultipleKorea, Republic of
-
Mayo ClinicNational Cancer Institute (NCI)CompletedMultiple Myeloma and Plasma Cell NeoplasmUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)National Cancer Institute (NCI); National Marrow Donor Program; Blood and Marrow...CompletedMultiple MyelomaUnited States
-
Lund University HospitalCelgene; Janssen, LP; Nordic Lymphoma GroupCompletedRelapsed/Refractory Mantle Cell LymphomaFinland, Denmark, Sweden, Norway
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Greater Washington Community FoundationTerminated
-
Novartis PharmaceuticalsCompletedA Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH) (ORION-5)Homozygous Familial HypercholesterolemiaHong Kong, Israel, Russian Federation, Serbia, South Africa, Taiwan, Turkey, Ukraine
-
GenmabAbbVieRecruitingFollicular Lymphoma (FL)Austria, Greece, Israel, Korea, Republic of, Spain, Hungary, Sweden, Switzerland, France, Poland, Taiwan, Australia, Denmark, New Zealand, Turkey, Italy, Netherlands, Belgium, Canada, South Africa, Czechia, Brazil, Germany, Argentina, United... and more
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingMultiple Myeloma | Plasmacytoma | Plasmacytoma of BoneUnited States
-
University of Michigan Rogel Cancer CenterActive, not recruitingMantle Cell LymphomaUnited States
-
Pharmacyclics LLC.Celgene CorporationCompletedDiffuse Large B Cell Lymphoma Refractory | Diffuse Large B Cell Lymphoma RelapsedUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)Completed
-
National Cancer Institute (NCI)CompletedNeurofibromatosis Type 1 | Recurrent Childhood Pilocytic Astrocytoma | Recurrent Childhood Visual Pathway GliomaUnited States, Canada, Australia, New Zealand
-
Celgene CorporationCompletedLow- or Intermediate-1-risk Myelodysplastic Syndrome (MDS)United States
-
CelgeneRecruitingMultiple MyelomaUnited States, France, Germany, Spain, United Kingdom, Italy
-
PfizerRecruitingMultiple MyelomaUnited States, Canada
-
Al-Rasheed University CollegeBaghdad Medical CityWithdrawnNewly Diagnosed Multiple MyelomaIraq
-
CelgeneCompletedMultiple MyelomaUnited States
-
PETHEMA FoundationCelgene; Pierre Fabre Medicament; Janssen, LPCompleted
-
PfizerIncyte Corporation; MorphoSys AGRecruitingDiffuse Large B-Cell LymphomaUnited States, Japan, Puerto Rico, Korea, Republic of
-
University of California, DavisCelgeneActive, not recruitingNon Hodgkin's LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSecondary Acute Myeloid Leukemia | Alkylating Agent-Related Acute Myeloid LeukemiaUnited States
-
Albert Einstein College of MedicineNational Cancer Institute (NCI)TerminatedAcute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome | Adult Acute Myeloid Leukemia in RemissionUnited States
-
University of California, San DiegoGenentech, Inc.; Celgene CorporationWithdrawnChronic Lymphocytic LeukemiaUnited States
-
Gruppo Italiano Studio LinfomiUnknown
-
PETHEMA FoundationJanssen PharmaceuticaRecruitingHigh-Risk de Novo Multiple MyelomaSpain
-
Antengene CorporationRecruitingDiffuse Large B-cell Lymphoma | Indolent Non-Hodgkin LymphomaChina
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham... and other collaboratorsTerminatedChronic Lymphocytic Leukemia | Small Lymphocytic LeukemiaUnited States
-
Fengmei LianPeking Union Medical College Hospital; Huashan Hospital; Chengdu University of... and other collaboratorsUnknownDiabetic Peripheral Neuropathy Type 2China
-
Hoffmann-La RocheRecruitingRelapsed or Refractory Follicular LymphomaUnited States, Korea, Republic of, Taiwan, China, Spain, United Kingdom, Australia, France, Germany, Japan, Turkey, Brazil, Poland, Ukraine, Italy, Russian Federation
-
Contera PharmaBukwang PharmaceuticalActive, not recruitingDyskinesiasFrance, Germany, Italy, Korea, Republic of, Spain
-
University of California, San DiegoTerminated
-
NovartisCompletedAcute Blunt Soft Tissue Injuries/ContusionsUnited States
-
William Beaumont HospitalsTerminatedFibrosis, Liver | Cirrhosis, Liver | Steatohepatitis, Nonalcoholic | Fatty Liver DiseaseUnited States
-
Vanderbilt UniversityMerck Sharp & Dohme LLCWithdrawnPeripheral Artery Disease
-
Mayo ClinicNational Cancer Institute (NCI)Completed
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.Completed
-
University of ChicagoNational Cancer Institute (NCI)Active, not recruitingStage I Multiple Myeloma | Stage II Multiple Myeloma | Stage III Multiple MyelomaUnited States, Canada
-
AmgenActive, not recruitingRelapsed Refractory Multiple MyelomaIndia
-
ECOG-ACRIN Cancer Research GroupNational Cancer Institute (NCI)Completed